Price$5.19-2.32 (-30.87%)
2026-04-212026-07-24
News · 26 weeks180%
2026-02-012026-07-26
Mix790d
- SEC Filings4(57%)
- Other2(29%)
- Insider1(14%)
Latest news
25 items- INSIDERSEC Form 3 filed by new insider Neo Alton Chun How3 - Basel Medical Group Ltd (0002004489) (Issuer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- PRBMGL Regains Compliance With Nasdaq Minimum Bid Price RequirementSingapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company") today announced that it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq minimum bid price rule. On January 22, 2026, Nasdaq notified the Company that its ordinary shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of The Nasdaq Stock Market. Since then, Nasdaq has determined that for the last 10 consecutive business days, from June 23, 2026 to July 7, 2026, the closing bid price of the Company’s ordinary shares has been at $1.00 per share or greater. Accordingly,
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- PRBMGL to Effect Reverse Share Split on June 22, 2026SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), a medical clinic operator in Singapore, today announced that the Company's board of directors has approved the consolidation of the Company's issued and outstanding shares of the Company on a 1-for-12 ratio with the marketplace effective date of June 22, 2026. The objective of the reverse share split is to enable the Company to recomply with Nasdaq Marketplace Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1 per share. According to the law of the British Virgin Islands, the jurisdiction of the Company's incorporation, and its memorandum and articles of
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- INSIDERSEC Form 3 filed by new insider Soong Kwek Yoon3 - Basel Medical Group Ltd (0002004489) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lu Jianing Jn3 - Basel Medical Group Ltd (0002004489) (Issuer)
- INSIDERSEC Form 3 filed by new insider Chen Tony3 - Basel Medical Group Ltd (0002004489) (Issuer)
- INSIDERSEC Form 3 filed by new insider Chhoa Darren Yen Feng3 - Basel Medical Group Ltd (0002004489) (Issuer)
- INSIDERSEC Form 3 filed by new insider Tan Boon Chye3 - Basel Medical Group Ltd (0002004489) (Issuer)
- INSIDERSEC Form 3 filed by new insider Fung Keng Leong3 - Basel Medical Group Ltd (0002004489) (Issuer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- PRCompliance With Nasdaq Periodic Filing RequirementSingapore, March 24, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company") today announced that it has received notification from Nasdaq that based on the Company's amended annual report on Form 20-F for the fiscal year of 2025, which was filed with the SEC on March 13, 2026, Nasdaq Staff has now determined that the Company has complied with the periodic filing requirement for The Nasdaq Stock Market under Listing Rule 5250(c)(1) (the "Periodic Filing Rule"). Accordingly, the prior deficiency relating to the Periodic Filing Rule has now been resolved. About Basel Medical Group Ltd Basel Medical is a Singapore-based provider of orthopedic and trauma services, spor
- SECAmendment: SEC Form 20-F/A filed by Basel Medical Group Ltd20-F/A - Basel Medical Group Ltd (0002004489) (Filer)
- INSIDERSEC Form 3 filed by new insider Freudenthaler Paul D3 - Basel Medical Group Ltd (0002004489) (Issuer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- PRReceipt of Delinquency Notification from NasdaqSingapore, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), today announced that it has received notification from Nasdaq that based on the closing bid price of the Company's shares for the last 30 consecutive business days, the Company no longer meets the requirements under Nasdaq's Listing Rules (the "Rules") for listed securities to maintain a minimum bid price of $1 per share. The Rules provide the Company a compliance period of 180 calendar days in which to regain compliance. If at any time during this 180 day period the closing bid price of the Company's security is at least $1 for a minimum of ten consecutive business days, Nasdaq will provid
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
- PRReceipt of Delinquency Notification from NasdaqSingapore, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), today announced that it has received notification from Nasdaq that the Company's annual report on Form 20-F for the fiscal year ended June 30, 2025 was incomplete and that the Company is delinquent in its filing obligations. This was because such report failed to include an opinion from the Company's auditor, NLA DFK Assurance PAC, on the Company's financial statements. Pursuant to Listing Rule 5250(c)(1), companies shall timely file all required periodic financial reports with the United States Securities and Exchange Commission, and annual reports filed shall contain audited financial stat
- SECSEC Form NT 20-F filed by Basel Medical Group LtdNT 20-F - Basel Medical Group Ltd (0002004489) (Filer)
- SECSEC Form 6-K filed by Basel Medical Group Ltd6-K - Basel Medical Group Ltd (0002004489) (Filer)
BMGL FAQ
5 questionsWhere does BMGL stock trade?
Basel Medical Group Ltd (BMGL) is listed on NASDAQ.What sector and industry is BMGL in?
Basel Medical Group Ltd operates in the Health Care sector, Medical/Nursing Services industry.When did Basel Medical Group Ltd go public?
Basel Medical Group Ltd (BMGL) completed its IPO in 2025.What companies are similar to BMGL?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), CHE (Chemed Corp), HIMS (Hims & Hers Health Inc.), LFST (LifeStance Health Group Inc.), AMED (Amedisys Inc). Compare BMGL side-by-side with any of them on Quantisnow.How can I track BMGL on Quantisnow?
Quantisnow aggregates Basel Medical Group Ltd's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BMGL to receive live email and push alerts on every new disclosure.